Skip to main content
https://pbs.twimg.com/media/Fhe1PdNWYAAs660.jpg
ATOM study, Abs 1314, greater proportion of men with OP on abaloparatide vs placebo met the definition of a >3% responder at the LS, TH, and FN. #ACR22 @RheumNow https://t.co/q6gcX5Azts https://t.co/WEjqbl14ZN
Dr. Rachel Tate
13-11-2022
×